Vaccine

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical…

1 year ago

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform…

1 year ago

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025GAITHERSBURG, Md., Sept. 25, 2024…

1 year ago

CS Genetics Appoints Bill Colston, PhD, as Chief Executive Officer

Experienced life-science entrepreneur to drive next generation of single cell biology SAN DIEGO and CAMBRIDGE, England, Sept. 24, 2024 /PRNewswire/…

1 year ago

Tips to Be Prepared for Cooler Weather

MISSION, Kan., Sept. 24, 2024 /PRNewswire/ -- (Family Features) Although cold weather isn't directly to blame when you get sick,…

1 year ago

InteliChart Enters New Agreement with Office Practicum to Amplify Patient Engagement for Pediatric Practices

Enhanced benefits and award-winning patient engagement solutions for pediatric practices. CHARLOTTE, N.C., Sept. 24, 2024 /PRNewswire/ -- InteliChart, an award-winning…

1 year ago

Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results

Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within…

1 year ago

Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference

MALVERN, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused…

1 year ago

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…

1 year ago